tetramethylpyrazine has been researched along with Fetal Growth Restriction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZJ; Hu, CX; Jin, S; Li, SW; Lin, YF; Ling, Y; Wang, MH; Yao, MZ | 1 |
| Ma, T; Wen, L; Xu, J | 1 |
2 other study(ies) available for tetramethylpyrazine and Fetal Growth Restriction
| Article | Year |
|---|---|
Expression of soluble vascular endothelial growth factor receptor-1 and placental growth factor in fetal growth restriction cases and intervention effect of tetramethylpyrazine.
Topics: Animals; Female; Fetal Development; Fetal Growth Retardation; Humans; Placenta; Placenta Growth Factor; Pregnancy; Pregnancy Proteins; Pyrazines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Vascular Endothelial Growth Factor Receptor-1; Vasodilator Agents | 2014 |
[Study on relativity between oxygen free radical and thromboxane B2, 6-keto-PGF1 alpha during ligustrazine treatment of intrauterine growth retardation].
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Female; Fetal Growth Retardation; Free Radical Scavengers; Humans; Pregnancy; Pyrazines; Superoxide Dismutase; Thromboxane B2 | 1998 |